Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Youn et al., Scientific Reportss, 2018, 8: 12323, DOI:10.1038/s41598-018-30513-7 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Taler, Mol Endocrinology 2003;17:1580 | ||
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Youn et al., Scientific Reports, 2018, 8:12323, DOI:10.1038/s41598-018-30513-7 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P. Sosa et al., Aging and Disease, 2018, 9(5): 769-784, doi.org/10.14336/AD.2017.1214 | Link | |
BV-2 |
Mouse microglial cell line | Mouse | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M.-J. Choi et al., Biochemical Pharmacology, 2017, 144: 120-131 | |||
BT549 |
Human mammary gland cells | ATCC HTB-122 | Human | breast | unknown | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
BT-20 |
Human breast cancer cell line | ATCC HTB-19 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. A. Zhang et al., Bio Protoc., 2018, 8 (1): doi:10.21769/BioProtoc.2680 | Link | ||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Crummy et al., J. Biol. Chem., 2019, doi/10.1074/jbc.RA119.007504 | Link | ||
beta-TC6 |
Mouse pancreatic tumor (insulinoma) derived ß cell line | ATCC CRL-11506 | Mouse | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Tsuruta et al., Hormone and Metabolic Research 2017, DOI: 10.1055/s-0043-121467 | ||
ATC1 |
Murine adrenocortical tumor cell line | Murine | other | cell line | siRNA | RNA-Interference | Metafectene | publication | A.-M. Lefrancois-Martinez et al., J. Biol. Chem., Sep 2011; 286: 32976 - 32985 | Link | |||
ATC1 |
Murine adrenocortical tumor cell line | Murine | other | cell line | siRNA | RNA-Interference | Metafectene | publication | A.-M. Lefrancois-Martinez et al., J. Biol. Chem., 2011, 286 (38) : 32976–32985, DOI 10.1074/jbc.M111.218016 | Link | |||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
ASBhTERT |
PCNT defective hTERT immortalized cell line | unknown | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Stiff et al., Hum. Mol. Genet., Apr 2016; 25: 1574 - 1587 | Link | ||
AS4.1 |
Mouse kidney tumor cell line | ATCC CRL-2193 | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. H. Vogel, Dissertation, 2021, Universität Greifswald | Link | |
AS4.1 |
Mouse kidney tumor cell line | ATCC CRL-2193 | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H. Wanka et al., J. Cell. Mol. Med., 2017, 21 (7): 1394-1410 | Link | |
aNS |
Mouse adult neurospheres (formed by stem & progenitor cells) | Mouse | unknown | stem cell | siRNA | RNA-Interference | Metafectene PRO | publication | A.-C. Hau et al., Scientific Reports, 2021, 11: 21013, doi.org/10.1038/s41598-021-99968- | Link | |||
aNS |
Adult Neurospheres (Sphere-forming cells isolated from the lateral walls of the lateral ventricle of C57BL/6 mice) | Mouse | nervous system | unknown | siRNA | RNA-Interference | Metafectene PRO | publication | B. M. Grebbin et al., Development, Jul 2016; 143: 2281 - 2291 | Link | |||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Bhandari et al., Biochem. and Biophys. Res. Commun., 2016, 475: 119-124 | |||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | T. S. Steigedal et al., In Vitro Cell. Dev.Biol. - Animal, 2013, 49: 162–169, DOI 10.1007/s11626-013-9588-2 | Link | ||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L.-K. M. Selvik et al., PLoS ONE, 2014, 9(11): e112485, doi:10.1371/journal.pone.0112485 | Link | ||
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. V. Rao et al., BMC Cancer, 2017, 17:68, DOI 10.1186/s12885-017-3055-5 | Link | |
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Rocco, et al., Lab. Investigation, 2012, 92: 1407–1418, doi:10.1038/labinvest.2012.100 | Link | |
A818-1 |
Human pancreatic ductal adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link |